Use of management processes other than those used as quality indicators, and recorded severity of pain and functional limitation, by cluster
| n (column %) | Total n (%) | Cluster | P value* | |||
| High (n=659) | Moderate (n=184) | Low (n=286) | None (n=595) | |||
| Opioid prescribed | 557 (33) | 236 (36) | 54 (29) | 94 (33) | 173 (29) | 0.06 |
| Oral NSAID prescribed | 284 (17) | 130 (20) | 21 (11) | 49 (17) | 84 (14) | 0.01 |
| X-ray requested | 263 (15) | 142 (22) | 30 (16) | 52 (18) | 39 (7) | <0.01 |
| n with pain record | 1092 | 645 | 177 | 263 | 7 | 0.001† |
| No pain | 16 (1) | 4 (<1) | 7 (4) | 4 (2) | 1 | |
| Mild pain | 348 (32) | 187 (29) | 69 (39) | 91 (35) | 1 | |
| Moderate pain | 582 (53) | 357 (55) | 84 (47) | 136 (52) | 5 | |
| Severe pain | 146 (13) | 97 (15) | 17 (10) | 32 (12) | 0 | |
| n with function record | 1070 | 646 | 174 | 250 | 0 | 0.004† |
| No limitation | 101 (9) | 46 (7) | 29 (16) | 26 (10) | 0 | |
| Mild limitation | 456 (43) | 276 (43) | 73 (42) | 107 (43) | 0 | |
| Moderate limitation | 427 (40) | 277 (43) | 57 (33) | 93 (37) | 0 | |
| Severe limitation | 86 (8) | 47 (7) | 15 (9) | 24 (10) | 0 | |
*χ2 test.
†Excluding None cluster.
NSAID, non-steroidal anti-inflammatory drug.